Stock Market News3 weeks AbbVie Beats on Q4 Earnings & Sales, Raises Sales View for Key Drugs Zacks
ABBV’s fourth-quarter earnings and sales beat estimates. Management raises the 2027 forecast for newer immunology drugs to more than $31 billion.
XABBV’s fourth-quarter earnings and sales beat estimates. Management raises the 2027 forecast for newer immunology drugs to more than $31 billion.
X